Yutiq Implant
Product Images NDC 68611-180

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Yutiq (NDC 68611-180). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ani Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Yutiq 01)

Figure 1 (Yutiq 01)
A line graph titled 'Mean IOP During the Studies' depicting mean intraocular pressure (mmHg) on the vertical axis versus time in months on the horizontal axis. Two groups are shown: YUTIQ (N=226) with a solid line and Sham (N=94) with a dashed line, illustrating changes in intraocular pressure over a 12-month period.*
FDA Label Image

Chemical Structure (Yutiq 02)

Chemical Structure (Yutiq 02)
Chemical structure of fluocinolone acetonide, the active ingredient in YUTIQ implant. The diagram shows the molecular arrangement including hydroxyl, ketone, and fluorine substituents characteristic of this corticosteroid compound.*
FDA Label Image

Figure 2 (Yutiq 03)

Figure 2 (Yutiq 03)
Two Kaplan-Meier curves showing time to first recurrence of uveitis in all randomized subjects from two studies comparing YUTIQ intravitreal implant versus sham injection over approximately 390 days. The y-axis represents probability recurrence, and the x-axis shows time in days. Both graphs illustrate lower recurrence probability for YUTIQ compared to sham injection.*
FDA Label Image

Principal Display Panel (Kit Carton)

Principal Display Panel (Kit Carton)
YUTIQ 0.18 mg intravitreal implant packaging label showing the proprietary name, active ingredient fluocinolone acetonide, and strength. The label states the implant is a single-dose applicator with a 25 gauge needle. Manufactured for Alimera Sciences, Inc., with storage instructions and disposal warnings included.*
FDA Label Image

Principal Display Panel (Inner Pouch)

Principal Display Panel (Inner Pouch)
Label for YUTIQ 0.18 mg implant containing fluocinolone acetonide for intravitreal use. The label includes storage instructions (15°C to 30°C), warnings, and states it contains one sterile single-dose applicator. The labeler is Alimera Sciences, Inc. and features a barcode along with NDC 68611-180-01.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.